Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world Study

@inproceedings{Kebernik2018DualAT,
  title={Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world Study},
  author={Julia Kebernik and Martin Borlich and Ralph Toelg and Mohamed El-Mawardy and Mohamed M. Abdel-Wahab and Gert Richardt},
  booktitle={Cardiology and therapy},
  year={2018}
}
IntroductionFor patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), proper antithrombotic therapy is equivocal. Current guidelines recommend triple therapy, which carries a high risk of bleeding. Recent large trials suggest that dual therapy (DT) with novel oral anticoagulant (NOAC) plus P2Y12 inhibitor can be an appropriate alternative, but real-world data for this alternative are scarce and the optimal duration of DT has not yet been established… CONTINUE READING
BETA
1
Twitter Mention

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 14 REFERENCES

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.

  • European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • 2018
VIEW 2 EXCERPTS

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

  • European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • 2016
VIEW 1 EXCERPT

Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients.

  • Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2015
VIEW 1 EXCERPT

Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome in the real world: data from the Berlin AfibACS registry

B Maier, C Hagenbarth, H Theres
  • Cardiol J. 2014;21:465–73
  • 2014
VIEW 1 EXCERPT